Dean Hickman

Title: Dean Hickman: Innovator in Beta-Secretase Modulation

Introduction

Dean Hickman is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of Beta-secretase enzyme activity. His work is crucial for the development of treatments for diseases such as Alzheimer's.

Latest Patents

Dean Hickman holds 2 patents, with his latest inventions focusing on Beta-Secretase modulators and methods of use. These patents describe a new class of compounds that are useful for modulating Beta-secretase enzyme activity. This modulation is essential for treating Beta-secretase mediated diseases, including Alzheimer's disease and related conditions. The compounds are defined by a general Formula I, which includes specific variables that are detailed in the patent. Additionally, the invention encompasses pharmaceutical compositions that include these compounds, as well as methods for their use in treating Alzheimer's and related diseases.

Career Highlights

Dean Hickman is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the pharmaceutical industry. His contributions have been instrumental in advancing research and development in the treatment of neurodegenerative diseases.

Collaborations

Throughout his career, Dean has collaborated with esteemed colleagues such as Wenge Zhong and Stephen A Hitchcock. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Dean Hickman is a prominent inventor whose work in Beta-Secretase modulation is paving the way for new treatments for Alzheimer's disease. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.